Comparison of a generic and a rhinitis-specific quality-of-life (QOL) instrument in patients with house dust mite allergy: Relationship between the SF-36 and rhinitis QOL questionnaire

Clinical and Experimental Allergy

Volumn 34, Issue 11, 2004, Pages 1673-1677

  Terreehorst, I ^a   Duivenvoorden, H J ^b   Tempels Pavlica, Z ^c,d   Oosting, A J ^e   De Monchy, J G R ^c   Bruijnzeel Koomen, C A F M ^e   Gerth Van Wijk, R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allergy; Canonical correlation; Redundancy analysis; Rhinitis; RQLQ; SF 36

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; CANONICAL ANALYSIS; CHILD; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; RHINITIS QOL QUESTIONNAIRE; SF 36 QUESTIONNAIRE;

ADOLESCENT; ADULT; CHILD; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE-BLIND METHOD; DUST; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 9244234297     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02096.x     Document Type: Article

References (37)

1. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
2. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Miller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47:76-83.
3. Molen van der T, Postma DS, Schreurs AJ, Bosveld HE, Sears MR, Meyboom de Jong B. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 1997; 6:353-61.
4. Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994; 149:371-5.
5. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-6.
6. Baiardini I, Pasquali M, Giardini A et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58:289-94.
7. Bousquet J, Duchateau J, Pignat JC et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996; 98:309-16.
8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
9. Pariente PD, LePen C, Los F, Bousquet J. Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 1997; 12:585-95.
10. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone dipropionate nasal spray: regular vs. "as required" use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1990; 86:380-6.
11. Juniper EF, Willms DG, Guyatt GH, Ferrie PJ. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. Cmaj 1992; 147:887-92.
12. Kremer B, Klimek L, Bullinger M, Mosges R. Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? Allergy 2001; 56:957-63.
13. de Graaf-in't Veld T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996; 98:508-13.
14. Edfors-Lubs ML. Allergy in 7000 twin pairs. Acta Allergol 1971; 26:249-85.
15. Peckham C, Butler N. A national study of asthma in childhood. J Epidemiol Community Health 1978; 32:79-85.
16. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106:201-5.
17. Terreehorst I, Oosting AJ, Tempels-Pavlica Z et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy 2002; 32:1160-5.
18. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z et al. The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites. Allergy 2002; 57:919-25.
19. Terreehorst I, Hak E, Oosting AJ et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003; 349:237-46.
20. Aaronson NK, Muller M, Cohen PD et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51:1055-68.
21. Keller SD, Bayliss MS, Ware JE Jr, Hsu MA, Damiano AM, Goss TF. Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods. Health Serv Res 1997; 32:367-84.
22. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
23. Ware JE Jr, Keller SD, Gandek B, Brazier JE, Sullivan M. Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment. Int J Technol Assess Health Care 1995; 11:525-51.
24. Ware JE Jr, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998; 7:235-44.
25. Morrison D. Multivariate statistical methods. New York: McGraw-Hill, 1967.
26. Anderson TW. Introduction to multivariate statistical analysis. New York: Wiley, 1958.
27. Cooley W, Lohnes P. Multivariate data analysis. New York: Wiley, 1971.
28. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000; 162:1391-6.
29. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001; 108:545-53.
30. Van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 2000; 30:891-9.
31. Ellis AK, Day JH, Lundie MJ. Impact on quality of life during an allergen challenge research trial [In Process Citation]. Ann Allergy Asthma Immunol 1999; 83:33-9.
32. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999; 52:187-92.
33. Juniper EF, Thompson AK, Roberts JN. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002; 57:201-6.
34. Johansson SG, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-24.
35. Barnes KC. Evidence for common genetic elements in allergic disease. J Allergy Clin Immunol 2000; 106:8192-200.
36. Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage 2000; 20:12-8.
37. Sprangers MA, de Regt EB, Andries F et al. Which chronic conditions are associated with better or poorer quality of life? [In Process Citation]. J Clin Epidemiol 2000; 53:895-907.